Recent reports indicate that clinics specializing in psychedelic therapies have experienced a surge in appointments. According to a recent article, "Post-election stress has driven a surge in Americans seeking psychedelic therapy for relief, with clinics reporting record appointments." (Benzinga)
The American Psychological Association's 2024 Stress in America survey revealed that 77% of U.S. adults consider the nation's future a significant source of stress. (American Psychological Association) This widespread anxiety has prompted many to seek treatments beyond traditional therapy and medication.
Ketamine therapy, in particular, has garnered attention for its rapid antidepressant effects. A study published in the Harvard Gazette highlighted ketamine's efficacy in treating treatment-resistant depression, offering hope to those who have not found relief through conventional methods. (APA)
Golden Afternoon Ketamine Clinic, based in Los Angeles, is committed to supporting individuals during these challenging times. To assist those experiencing post-election stress, the clinic is offering a special discount of $250 off treatments for new clients. This offer applies to both single sessions and treatment packages, aiming to make relief more accessible to those in need.
Golden Afternoon Ketamine Clinic is dedicated to providing compassionate and effective care, utilizing evidence-based therapies to help clients achieve mental wellness. Their team of experienced professionals offers personalized treatment plans tailored to each individual's needs.
For more information or to schedule an appointment, please visit Golden Afternoon Ketamine Clinic.
Dr. Jenn Ellice
Golden Afternoon Ketamine Clinic
+1 323-627-9881
email us here
Visit us on social media:
Instagram
Dr. Jenn Discusses Ketamine Therapy on the Kevin Rose podcast
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.